These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17642248)

  • 41. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic.
    Keane J
    Rheumatology (Oxford); 2005 Jun; 44(6):714-20. PubMed ID: 15741198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis and anti-TNF-alpha treatment.
    Ormerod LP
    Thorax; 2004 Nov; 59(11):921. PubMed ID: 15516463
    [No Abstract]   [Full Text] [Related]  

  • 43. Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists.
    Hatemi G; Melikoglu M; Ozbakir F; Tascilar K; Yazici H
    Arthritis Res Ther; 2012 Jun; 14(3):R147. PubMed ID: 22709461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab].
    Takasaka N; Toyota E; Shimada M; Ariga H; Teramoto S; Akagawa S
    Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):60-5. PubMed ID: 20163024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union.
    Smith MY; Attig B; McNamee L; Eagle T
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1168-73. PubMed ID: 22794309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
    Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S
    Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice.
    Bigbee CL; Gonchoroff DG; Vratsanos G; Nadler SG; Haggerty HG; Flynn JL
    Arthritis Rheum; 2007 Aug; 56(8):2557-65. PubMed ID: 17665452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy.
    Lioté H; Lioté F
    Joint Bone Spine; 2011 Jul; 78(4):352-7. PubMed ID: 21251863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of tuberculosis infection in anti-TNF-α biological therapy: from bench to bedside.
    Xie X; Li F; Chen JW; Wang J
    J Microbiol Immunol Infect; 2014 Aug; 47(4):268-74. PubMed ID: 23727394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disseminated tuberculosis secondary to adalimumab.
    Pednekar M; Chandra AB; Chandra PA
    Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon γ assays in the diagnosis of tuberculosis infection in psoriasis patients who are candidates for biologic therapies.
    Domínguez J; Vilavella M; Latorre I
    Actas Dermosifiliogr; 2012 Dec; 103(10):880-6. PubMed ID: 23157912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunodiagnosis of mycobacterial infection].
    Tomoda K; Yoshikawa M; Kimura H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():152-5. PubMed ID: 16111214
    [No Abstract]   [Full Text] [Related]  

  • 54. [Screening for tuberculosis before TNFα treatment in routine rheumatic care in Iceland. Result from the nationwide ICEBIO registry].
    Bjorgulfsson TM; Gröndal G; Blondal T; Gudbjornsson B
    Laeknabladid; 2018 Mai; 104(5):231-235. PubMed ID: 29717989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuberculosis infections and tumor necrosis factor alpha antagonists.
    Gan J; Manadan AM; Sequiera W; Block JA
    Am J Ther; 2013 Jan; 20(1):73-8. PubMed ID: 21519217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recommendations for the prevention and management of tuberculosis in patients treated with tumor necrosis factor alpha inhibitors: a consensus of lithuanian pulmonologists and rheumatologists].
    Malakauskas K; Zablockis R; Venalis A; Butrimienė I; Baranauskaitė A; Nargėla RV; Sakalauskas R
    Medicina (Kaunas); 2011; 47(3):187-91. PubMed ID: 21822042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The risk of tuberculosis in patients treated with TNF antagonists.
    Salgado E; Gómez-Reino JJ
    Expert Rev Clin Immunol; 2011 May; 7(3):329-40. PubMed ID: 21595599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management.
    Kasiraman V; Atwan AA; Durojaiye OC; Kalavala M; Piguet V
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients.
    Hanta I; Ozbek S; Kuleci S; Kocabas A
    Clin Rheumatol; 2008 Sep; 27(9):1083-6. PubMed ID: 18320137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents.
    Hejazi ME; Ahmadzadeh A; Khabbazi A; Ebrahimi A; Farmani M; Hejazi Y
    BMC Infect Dis; 2020 Jul; 20(1):464. PubMed ID: 32615992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.